Trials / Completed
CompletedNCT01029522
Dyslipidemia in Cardiovascular Disease
A Multi-center, Randomized, Double-blinded Equivalence Clinical Trial to Evaluate Efficacy and Safety of LipiLou 20 mg Versus Lipitor 20 mg in Hypercholesterolemic Patients With Higher Risk Cardiovascular Disease in Korea
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 244 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, randomized, double-blinded equivalence clinical trial to evaluate efficacy and safety of LipiLou 20 mg versus Lipitor 20 mg in hypercholesterolemic patients with higher risk cardiovascular disease in Korea.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin (Lipilou) | treatment of dyslipidemia administration : PO, qod |
| DRUG | Atorvastatin (Lipitor) | treatment of dyslipidemia administration : PO, qod |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2008-10-01
- Completion
- 2009-11-01
- First posted
- 2009-12-10
- Last updated
- 2012-08-09
Source: ClinicalTrials.gov record NCT01029522. Inclusion in this directory is not an endorsement.